Skip to main content
Clinical Trials/EUCTR2017-003003-22-DK
EUCTR2017-003003-22-DK
Active, not recruiting
Phase 1

postoperative effect of optimal multimodal pain management supplemented with systemic single dose of Dexamethason in the first week after UKA. Low dose (8mg) or mean dose

Aalborg University Hospital, Department of Orthopedics0 sites70 target enrollmentOctober 10, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Aalborg University Hospital, Department of Orthopedics
Enrollment
70
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2017
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Aalborg University Hospital, Department of Orthopedics

Eligibility Criteria

Inclusion Criteria

  • patients \< 18 years scheduled for UKA
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 35
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 35

Exclusion Criteria

  • Fertil women, daily use of opioids, NSAID or glucocorticoid, allergi to medicin used in the trial,alcohol abuse, cognictive dysfunction, severe kidney or hesrt disease, language barrier, operation in generel anaesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials